AJ Wealth Strategies’s Amneal Pharmaceuticals AMRX Stock Holding History

AJ Wealth Strategies’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,242	Closed	-$48K	–	307
2022 Q2	$48K	Hold	15,242	–	–	﹤0.01%	300
2022 Q1	$64K	Hold	15,242	–	–	﹤0.01%	313
2021 Q4	$73K	Hold	15,242	–	–	﹤0.01%	302
2021 Q3	$81K	Hold	15,242	–	–	﹤0.01%	291
2021 Q2	$78K	Hold	15,242	–	–	﹤0.01%	270
2021 Q1	$103K	Hold	15,242	–	–	0.01%	257
2020 Q4	$70K	Hold	15,242	–	–	0.01%	238
2020 Q3	$59K	Hold	15,242	–	–	0.01%	218
2020 Q2	$73K	Hold	15,242	–	–	0.01%	200
2020 Q1	$53K	Hold	15,242	–	–	0.01%	175
2019 Q4	$73K	Hold	15,242	–	–	0.01%	119
2019 Q3	$44K	Buy	+15,242	New	+$53.2K	0.01%	115

Other funds holding AMRX

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AJ Wealth Strategies's AMRX Position: Q3 2022 in Review

AJ Wealth Strategies sold out of Amneal Pharmaceuticals (AMRX) in Q3 2022, closing a stake of 15,242 shares — an estimated $48K sold.

AJ Wealth Strategies first reported a position in AMRX in Q3 2019 and held it in 12 quarters. The position peaked at $103K in Q1 2021. 154 funds tracked by Wall St. Rank hold AMRX as of Q3 2022.

AJ Wealth Strategies reported no remaining Amneal Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
AJ Wealth Strategies sold 15,242 Amneal Pharmaceuticals shares in Q3 2022, an estimated $48K.
AJ Wealth Strategies first reported a position in Amneal Pharmaceuticals in Q3 2019 and held it in 12 quarters.
AJ Wealth Strategies's Amneal Pharmaceuticals position peaked at $103K in Q1 2021.
154 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2022.

Based on AJ Wealth Strategies's 13F filing for Q3 2022, filed 27 Oct 2022.